TR201000680A2 - Tiotropyum, formoterol ve budesonid içeren farmasötik bileşimler - Google Patents

Tiotropyum, formoterol ve budesonid içeren farmasötik bileşimler

Info

Publication number
TR201000680A2
TR201000680A2 TR2010/00680A TR201000680A TR201000680A2 TR 201000680 A2 TR201000680 A2 TR 201000680A2 TR 2010/00680 A TR2010/00680 A TR 2010/00680A TR 201000680 A TR201000680 A TR 201000680A TR 201000680 A2 TR201000680 A2 TR 201000680A2
Authority
TR
Turkey
Prior art keywords
formoterol
budesonide
pharmaceutical compositions
compositions containing
containing tiotropium
Prior art date
Application number
TR2010/00680A
Other languages
English (en)
Inventor
B�Lg�� Mahmut
Original Assignee
B�Lg�� Mahmut
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by B�Lg�� Mahmut filed Critical B�Lg�� Mahmut
Priority to TR2010/00680A priority Critical patent/TR201000680A2/tr
Priority to EP11706963.3A priority patent/EP2528585B1/en
Priority to PCT/TR2011/000019 priority patent/WO2011093817A1/en
Publication of TR201000680A2 publication Critical patent/TR201000680A2/tr
Priority to US13/531,972 priority patent/US8834931B2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators

Abstract

Solunum yolları hastalıklarında kullanılmak üzere, tiotropyum, formoterol ve budesonid ve/veya bunların farmasötik açıdan kabul edilebilen türevlerini içeren ilaç ve bu ilacın astım ve KOAH başta olmak üzere solunum yolları hastalıklarının semptomatik ve/veya profilaktik tedavisinde kullanımı.
TR2010/00680A 2009-12-25 2010-01-29 Tiotropyum, formoterol ve budesonid içeren farmasötik bileşimler TR201000680A2 (tr)

Priority Applications (4)

Application Number Priority Date Filing Date Title
TR2010/00680A TR201000680A2 (tr) 2010-01-29 2010-01-29 Tiotropyum, formoterol ve budesonid içeren farmasötik bileşimler
EP11706963.3A EP2528585B1 (en) 2010-01-29 2011-01-28 Pharmaceutical compositions comprising tiotropium, formoterol and budesonide
PCT/TR2011/000019 WO2011093817A1 (en) 2010-01-29 2011-01-28 Pharmaceutical compositions comprising tiotropium, formoterol and budesonide
US13/531,972 US8834931B2 (en) 2009-12-25 2012-06-25 Dry powder formulation containing tiotropium for inhalation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TR2010/00680A TR201000680A2 (tr) 2010-01-29 2010-01-29 Tiotropyum, formoterol ve budesonid içeren farmasötik bileşimler

Publications (1)

Publication Number Publication Date
TR201000680A2 true TR201000680A2 (tr) 2011-08-22

Family

ID=43902565

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2010/00680A TR201000680A2 (tr) 2009-12-25 2010-01-29 Tiotropyum, formoterol ve budesonid içeren farmasötik bileşimler

Country Status (3)

Country Link
EP (1) EP2528585B1 (tr)
TR (1) TR201000680A2 (tr)
WO (1) WO2011093817A1 (tr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011093812A2 (en) * 2010-01-28 2011-08-04 Mahmut Bilgic Pharmaceutical formulation comprising tiotropium and budesonide in dry powder form
US8834931B2 (en) 2009-12-25 2014-09-16 Mahmut Bilgic Dry powder formulation containing tiotropium for inhalation
EP2804585A1 (en) * 2012-01-16 2014-11-26 Mahmut Bilgic Dry powder formulations comprising tiotropium, formoterol and budesonide
WO2013109210A1 (en) * 2012-01-16 2013-07-25 Mahmut Bilgic Dry powder formulations comprising budesonide
WO2013109219A1 (en) * 2012-01-16 2013-07-25 Mahmut Bilgic Dry powder formulations comprising tiotropium and carmoterol
WO2014007773A1 (en) * 2012-07-05 2014-01-09 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Compositions comprising muscarinic receptor antagonist and sorbitol
WO2014007772A2 (en) 2012-07-05 2014-01-09 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Inhalation compositions comprising glucose anhydrous
US20150165037A1 (en) * 2012-07-05 2015-06-18 Arven llac Sanayi Ve Ticaret A.S. Inhalation compositions comprising corticosteroid and sorbitol
WO2014007771A2 (en) 2012-07-05 2014-01-09 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Inhalation compositions comprising muscarinic receptor antagonist
GB201321712D0 (en) * 2013-12-09 2014-01-22 Pharmachemie Bv Dry Powder Inhaler
GB201321717D0 (en) * 2013-12-09 2014-01-22 Pharmachemie Bv Inhalable Medicaments
RU2016147569A (ru) * 2014-05-09 2018-06-13 Ногра Фарма Лимитед Способы лечения воспалительного заболевания кишечника
GB201408387D0 (en) * 2014-05-12 2014-06-25 Teva Pharmaceuticals Europ B V Treatment of respiratory disorders
CN115844860A (zh) * 2014-10-08 2023-03-28 萨宝公司 用于吸入使用的粉末形式的药物组合物及试剂盒
MA41271A (fr) * 2014-12-26 2017-10-31 Celgene Alpine Invest Company Ii Llc Méthodes d'utilisation d'oligonucléotides antisens ciblant smad7
TR201712424A2 (tr) * 2017-08-21 2019-03-21 Arven Ilac Sanayi Ve Ticaret Anonim Sirketi Kuru toz i̇nhalasyon bi̇leşi̇mleri̇

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE0004750D0 (sv) * 2000-12-19 2000-12-19 Astrazeneca Ab Novel formulation
DE10130371A1 (de) * 2001-06-23 2003-01-02 Boehringer Ingelheim Pharma Neue Arzneimittelkompositionen auf der Basis von Anticholinergika, Corticosteroiden und Betamimetika
EP2319583A1 (en) * 2002-08-29 2011-05-11 Cipla Ltd. Pharmaceutical products and compositions comprising salmeterol, budesonide and ipratropium
US7763280B2 (en) * 2002-11-28 2010-07-27 Boehringer Ingelheim Pharma Gmbh & Co. Kg Tiotropium containing powder formulation for inhalation
SE0303570L (sv) * 2003-12-03 2005-06-04 Microdrug Ag Fukt-känslig medicinsk produkt
BRPI0417097A (pt) * 2003-12-03 2007-03-13 Microdrug Ag inalador de pó seco de dose previamente medida para medicamentos sensìveis à umidade
EP2327403A3 (en) * 2007-02-19 2011-08-31 Cipla Limited Pharmaceutical combinations of at least two bronchodilators

Also Published As

Publication number Publication date
WO2011093817A1 (en) 2011-08-04
EP2528585B1 (en) 2019-07-24
EP2528585A1 (en) 2012-12-05

Similar Documents

Publication Publication Date Title
TR201000680A2 (tr) Tiotropyum, formoterol ve budesonid içeren farmasötik bileşimler
TR201000681A2 (tr) İnhalasyon yoluyla alınan kuru toz formülasyonları.
TR201000623A2 (tr) Yeni tiotropyum kombinasyonu.
EP2749283A3 (en) Combination of glycopyrronium and olodaterol
TR201000622A2 (tr) Tiotropyum içeren farmasötik kombinasyonlar.
WO2014064410A8 (en) Pharmaceutical composition
GB201205632D0 (en) Method and apparatus
WO2014016548A3 (en) Pharmaceutical composition comprising olodaterol and one or more further active pharmaceutical ingredient
TR201000733A2 (tr) Flutikazon, tiotropyum ve sodyum kromoglikat içeren farmasötik bileşimler.
IL232764A (en) Fluoromethyl6,5 - Dihydro - 4 H - [3,1] Oxazines, Pharmaceuticals Containing Them and Their Use in the Preparation of Medicines to Treat Alzheimer's Disease
MX2013000642A (es) Composiciones farmaceuticas.
CO7160008A2 (es) Derivados de estra- 1,3,5(10),16- tetraeno 3-sustituidos, métodos para su preparación, prepara-ciones farmaceúticas que los contienen, así como su uso para la preparación de medicamentos
MX2015015132A (es) Composiciones farmaceuticas inhalables y los dispositivos inhaladores que las contienen.
WO2014007770A3 (en) Inhalation compositions comprising corticosteroid and sorbitol
MX2016014695A (es) Combinaciones de bromuro de tiotropio, formoterol y budesonida para el tratamiento de enfermedad pulmonar obstructiva cronica.
EA201201397A1 (ru) Ингалятор, содержащий расслаиваемую блистерную упаковку
WO2014007771A3 (en) Inhalation compositions comprising muscarinic receptor antagonist
WO2011093818A3 (en) Pharmaceutical compositions comprising salmeterol and fluticasone
WO2011093815A3 (en) Pharmaceutical compositions comprising formoterol and mometasone
MX2015009891A (es) Composiciones farmaceuticas que comprenden particulas cristalinas de multicomponentes adecuadas para usar en terapia de inhalacion.
MX2015007731A (es) Formulacion farmaceutica que comprende ciclesonida.
UA115989C2 (uk) Фармацевтична композиція для інгалятора сухого порошку, що містить антагоністи мускаринових рецепторів тривалої дії
WO2011093811A3 (en) Pharmaceutical preparations comprising formoterol and fluticasone
TR201207226A2 (tr) Yeni inhalasyon aerosol formülasyonlar.
TR201207225A2 (tr) Bir inhalasyon formülasyonu.